NO129205B - - Google Patents

Download PDF

Info

Publication number
NO129205B
NO129205B NO00283/71A NO28371A NO129205B NO 129205 B NO129205 B NO 129205B NO 00283/71 A NO00283/71 A NO 00283/71A NO 28371 A NO28371 A NO 28371A NO 129205 B NO129205 B NO 129205B
Authority
NO
Norway
Prior art keywords
pyrimidine
thieno
acid
morpholino
general formula
Prior art date
Application number
NO00283/71A
Other languages
English (en)
Norwegian (no)
Inventor
E Woitun
G Ohnacker
B Narr
U Horch
R Kadatz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19702003714 external-priority patent/DE2003714C/de
Priority claimed from DE19702058086 external-priority patent/DE2058086A1/de
Priority claimed from DE19702058085 external-priority patent/DE2058085A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO129205B publication Critical patent/NO129205B/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO00283/71A 1970-01-28 1971-01-27 NO129205B (oth)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19702003714 DE2003714C (de) 1970-01-28 2 Piperazino 4 morpholino thieno eckige Klammer auf 3,2 d eckige Klammer zu pyrimidin und dessen Saureadditions salze
DE19702058086 DE2058086A1 (de) 1970-11-26 1970-11-26 Neue 4-Morpholino-thieno[3,2-d]pyrimidine,deren Salze und Verfahren zur Herstellung
DE19702058085 DE2058085A1 (de) 1970-11-26 1970-11-26 Neues Verfahren zur Herstellung von 4-Morpholino-thieno[3,2-d]pyrimidinen

Publications (1)

Publication Number Publication Date
NO129205B true NO129205B (oth) 1974-03-11

Family

ID=27182372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO00283/71A NO129205B (oth) 1970-01-28 1971-01-27

Country Status (9)

Country Link
US (1) US3763156A (oth)
AU (1) AU2468871A (oth)
BE (1) BE762135A (oth)
ES (2) ES387553A1 (oth)
FR (1) FR2081464B1 (oth)
GB (1) GB1309182A (oth)
IL (1) IL36079A0 (oth)
NL (1) NL7101043A (oth)
NO (1) NO129205B (oth)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570494A (en) * 1975-11-28 1980-07-02 Ici Ltd Thienopyrimidine derivatives and their use as pesticides
GB8912335D0 (en) * 1989-05-30 1989-07-12 Smithkline Beckman Intercredit Compounds
US5280026A (en) * 1989-05-30 1994-01-18 Smithkline Beecham Intercredit B.V. Thienopyrimidines
US5098902A (en) * 1991-03-18 1992-03-24 Warner-Lambert Company Method of treating neurodegenerative diseases
US6187777B1 (en) 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
GB0423653D0 (en) 2004-10-25 2004-11-24 Piramed Ltd Pharmaceutical compounds
DE502006004066D1 (de) * 2006-04-19 2009-08-06 Boehringer Ingelheim Pharma Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
CL2007001165A1 (es) * 2006-04-26 2008-01-25 Hoffmann La Roche 2-(1h-indazol-4-il)-6-(4-metanosulfonil-piperazin-1-ilmetil)-4-morfolin-4-il-tieno[3,2-d]pirimidina; procedimiento de preparacion; composicion farmaceutica; proceso de preparacion de dicha composicion; kit farmaceutico; y uso para tratar enfermedades tales como cancer, desordenes inmunes y enfermedades cardiovasculares.
PL2041139T3 (pl) * 2006-04-26 2012-05-31 Hoffmann La Roche Związki farmaceutyczne
CL2007001166A1 (es) 2006-04-26 2008-01-25 Piramed Ltd Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica
BRPI0717907A2 (pt) * 2006-12-07 2013-11-05 Genentech Inc "composto, composição farmacêutica, métodos para tratar um câncer, para inbir ou modular a atividade da lipídeo quinase, processo para a produçãoo de uma composição farmacêutica, uso de um composto e kit"
AR064155A1 (es) * 2006-12-07 2009-03-18 Piramed Ltd Compuestos de inhibidores de fosfoinositido-3 quinasa y metodos de uso
EP2207781B1 (en) 2007-09-24 2012-11-28 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
JP5341899B2 (ja) 2007-10-19 2013-11-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ヘテロ環置換ピペラジノ−ジヒドロチエノピリミジン
ATE542825T1 (de) * 2007-10-19 2012-02-15 Boehringer Ingelheim Int Substituierte piperidino-dihydrothienopyrimidine
JP5563466B2 (ja) 2007-10-19 2014-07-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規ピペラジノ−ジヒドロチエノピリミジン誘導体
JP5348725B2 (ja) 2007-10-25 2013-11-20 ジェネンテック， インコーポレイテッド チエノピリミジン化合物の製造方法
GB0721095D0 (en) * 2007-10-26 2007-12-05 Piramed Ltd Pharmaceutical compounds
CA2753285A1 (en) 2009-03-12 2010-09-16 Genentech, Inc. Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
SG182247A1 (en) * 2009-05-27 2012-08-30 Hoffmann La Roche Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
SG175708A1 (en) * 2009-05-27 2011-12-29 Genentech Inc Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
MX345155B (es) * 2009-10-12 2017-01-18 F Hoffmann-La Roche Ag * Combinaciones de un inhibidor de pi3k y un inhibidor de mek.
JP2013528787A (ja) 2010-04-16 2013-07-11 ジェネンテック， インコーポレイテッド Ｐｉ３ｋ／ａｋｔキナーゼ経路インヒビターの効果の予測バイオマーカーとしてのｆｏｘ０３ａ
WO2012088254A1 (en) 2010-12-22 2012-06-28 Genentech, Inc. Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
US9802954B2 (en) 2011-08-24 2017-10-31 Boehringer Ingelheim International Gmbh Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
BR112015020054A2 (pt) 2013-02-25 2017-08-29 Genentech Inc Método de detectar resistência aos efeitos terapêuticos de um inibidor de akt em uma célula cancerosa
US11098056B2 (en) * 2018-10-01 2021-08-24 Genzyme Corporation UDP glycosyltransferase inhibitors and methods of use
GB202014736D0 (en) * 2020-09-18 2020-11-04 Imperial College Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470356A1 (de) * 1964-01-15 1970-04-30 Thomae Gmbh Dr K Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
AU2468871A (en) 1972-07-27
BE762135A (fr) 1971-07-27
ES387554A1 (es) 1974-01-16
FR2081464A1 (oth) 1971-12-03
IL36079A0 (en) 1971-03-24
GB1309182A (en) 1973-03-07
ES387553A1 (es) 1974-01-16
FR2081464B1 (oth) 1975-04-18
NL7101043A (oth) 1971-07-30
US3763156A (en) 1973-10-02

Similar Documents

Publication Publication Date Title
NO129205B (oth)
JP2896532B2 (ja) 新規なピリミジン誘導体およびその製造方法
FI63587C (fi) Foerfarande foer framstaellning av anti-inflammatoriska halogenerade 4-hydroxi-2-alkyl-3-karbamoyl-2h-tieno-1,2-tiazin-1,1-dioxidderivat
CA2985547C (en) Substituted tetrahydroquinolinone compounds as ror gamma modulators
FI65435C (fi) Foerfarande foer framstaellning av immunitet raglerande och arrit motstaoende 5-(4-pyridyl)-6-(4-fluorfenyl)-2,3-dihydr oiidazo-(2,1-b)tiazol
JPH0784470B2 (ja) 活性化合物、その製法及びそれを含む医薬組成物
NO179674B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, heterosykliske N-oksidderivater av substituerte benzo[5,6Åsyklo-heptapyridiner
NO161373B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pteridin-derivater.
NO152373B (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 8-fenyl-purin-derivater
CA3061209A1 (en) Compound used as autophagy regulator, and preparation method therefor and uses thereof
NO160920B (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-piperazino-pteridin-derivater.
FI61899C (fi) Foerfarande foer framstaellning av antiflogistiska och antitrombotiska 6-substituerad-3-amino-4-fenyl-1h-pyrazolo(3,4-b)pyridiner
US4224445A (en) Thienothiazine derivatives
DD216019A5 (de) Verfahren zur herstellung heterocyclisch ankondensierter pyrazolo (3,4-d) pyridin-3-one
JPH0499768A (ja) ４―（４―フェニルピリジン―２―イル）ピペラジン―１―オキシド誘導体
IL93760A (en) History of N-3] 3-Ariyl) Hydroxyamino (methylphenyl [-3-) pyridyl (- H1, H3-pyrrolo] C-1,2 [thiazole-7-carboxamide, their preparation and pharmaceutical preparations containing them
US4213984A (en) 11-(Piperazino-acetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-ones and salts thereof
JP5635592B2 (ja) ５−アルキニル−ピリジン
US3843663A (en) 1,8-naphthyridine compounds
CS207619B2 (en) Method of making the new derivatives of 5,11-dihydro-6h-pyrido 2,3-b 1,4 benzodiazepin-6-on
JPS58128384A (ja) ベンゾジオキシン化合物、その製造方法、および精神作用障害治療用医薬組成物
JPH07505394A (ja) 橋渡しビスアリールカルビノール誘導体，組成物および使用法
DK148772B (da) Analogifremgangsmaade til fremstilling af 6-(4-morpholinophenyl)-4,5-dihydro-3(2h)-pyridazinoner eller syreadditionssalte deraf
NO812431L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-2-on-derivater.
JPH03106875A (ja) １―（３―ピリジルメチル）フタラジン誘導体